A Chemotherapeutic Approach to CNS Lymphoma and Leukaemia by the Systemic Administration of High Doses of Antimetabolites
- 1 January 1979
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Central nervous system involvement by ovarian carcinoma.A complication of prolonged survival with metastatic diseaseCancer, 1978
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyThe American Journal of Medicine, 1977
- Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphomaBlood, 1977
- Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1976
- Intrathecal n, n′, n′-triethylenethiophosphoramide [thio-tepa (NSC 6396)] in the treatment of malignant meningeal disease.Phase I-II studyCancer, 1976
- Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisitedBlood, 1976
- Methotrexate: Distribution in Cerebrospinal Fluid after Intravenous, Ventricular and Lumbar InjectionsNew England Journal of Medicine, 1975
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Intrathecal arabinosyl cytosine in meningeal leukemiaCancer, 1970